Skip to main content

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE FINDING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PADSEVONIL AS ADJUNCTIVE TREATMENT OF FOCAL-ONSET SEIZURES IN ADULT SUBJECTS WITH DRUG-RESISTANT EPILEPSY

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Epilepsy and Sleep

Awarded By

UCB Pharma, Inc.

Start Date

May 18, 2018

End Date

December 31, 2020
 

Administered By

Neurology, Epilepsy and Sleep

Awarded By

UCB Pharma, Inc.

Start Date

May 18, 2018

End Date

December 31, 2020